High Resolution Genomic Analysis of Breast Cancer
Author Information
Author(s): Tara L. Naylor, Joel Greshock, Yan Wang, Theresa Colligon, QC Yu, Virginia Clemmer, Tal Zaks, Barbara L. Weber
Primary Institution: University of Pennsylvania School of Medicine
Hypothesis
The study aims to analyze genomic aberrations in breast cancer at high resolution.
Conclusion
The study reveals common regions of DNA copy number gain and loss in breast cancer, suggesting potential therapeutic targets.
Supporting Evidence
- 79% of tumors exhibited amplification at 8q24.3.
- The most frequently lost tumor suppressor gene was RB1, lost in 26% of tumors.
- The study found a Pearson correlation coefficient of 0.843 for gains and 0.734 for losses between primary tumors and cell lines.
Takeaway
Researchers looked at breast cancer DNA to find changes that could help understand the disease better and find new treatments.
Methodology
The study used high-resolution array comparative genomic hybridization to analyze 47 primary breast tumors and 18 breast cancer cell lines.
Limitations
The small sample size may limit the ability to identify associations between specific aberrations and clinical characteristics.
Participant Demographics
The study included 47 fresh-frozen primary breast tumors and 18 breast cancer cell lines.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website